Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.


Mood disorders such as depression are among the most prevalent psychiatric disorders in the United States, but they are inadequately treated in a substantial proportion of patients. Accordingly, neuropsychiatric research has pivoted from investigation of monoaminergic mechanisms to exploration of novel mediators, including the role of inflammatory processes… (More)
DOI: 10.1146/annurev-pharmtox-010617-052823


Cite this paper

@article{Pfau2018InflammatoryMI, title={Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.}, author={Madeline L. Pfau and Caroline M{\'e}nard and Scott J Russo}, journal={Annual review of pharmacology and toxicology}, year={2018}, volume={58}, pages={411-428} }